Trent, Erika S.
Tan, Samantha X. L.
Cheng, Jessica Szu-Chi
Storch, Eric A.
Funding for this research was provided by:
Texas Child Mental Health Care Consortium (NECMHR01-FY24-024)
The Baylor College of Medicine Intellectual and Developmental Disabilities Research Center from the Eunice Kennedy Shriver NICHD (P50HD103555)
International OCD Foundation
REAM Foundation
National Institutes of Health
Article History
Accepted: 25 April 2025
First Online: 9 May 2025
Declarations
:
: This article does not contain any studies with human or animal subjects performed by any of the authors.
: Since no participant data was collected for this review article, no informed consent was necessary.
: Dr. Eric A. Storch reports receiving research funding to his institution from the Baylor College of Medicine Intellectual and Developmental Disabilities Research Center (P50HD103555) from the Eunice Kennedy Shriver NICHD, Ream Foundation, International OCD Foundation, and NIH. He is a consultant for Brainsway and Biohaven Pharmaceuticals. He owns stock less than $5000 in NView. He receives book royalties from Elsevier, Wiley, Oxford, American Psychological Association, Guildford, Springer, and Jessica Kingsley. Dr. Erika S. Trent reports receiving research funding to her institution from the Texas Child Mental Health Care Consortium (TCMHCC). The contents of this publication do not necessarily reflect the views or policies of the NIH, Ream Foundation, IOCDF, or TCMHCC. The mention of trade names, commercial products, or organizations does not imply endorsement by the US Government. The remaining authors have no relevant financial or non-financial competing interests to disclose.